Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome

被引:6
|
作者
Zhao, Ji-Meng [1 ]
Chen, Liu [1 ]
Zhou, Ci-Li [2 ]
Shi, Yin [1 ,2 ]
Li, Yu-Wei [1 ]
Shang, Hai-Xia [1 ]
Wu, Lu-Yi [1 ]
Bao, Chun-Hui [2 ]
Dou, Chuan-Zi [2 ]
Wu, Huan-Gan [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 201203, Peoples R China
[2] Shanghai Inst Acupuncture Moxibust & Meridian, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
5-HT4; RECEPTOR; MAST-CELLS; SEROTONIN; DIARRHEA;
D O I
10.1155/2016/9410505
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Aim. To compare whether there is different effect between electroacupuncture (EA) and moxibustion (Mox) on visceral hypersensitivity (their analgesic effects) in constipation-predominant irritable bowel syndrome (C-IBS). Methods. EA at 1 mA and 3 mA and Mox at 43 degrees C and 46 degrees C were applied to the Shangjuxu (ST37, bilateral) acupoint in rats with C-IBS and normal rats. An abdominal withdrawal reflex (AWR) score was used to assess visceral hypersensitivity. Toluidine blue staining was used to assess mast cell (MC) activity in colon of rats. Immunochemistry was used to measure 5-HT and 5-HT4 receptor expression in the colon. Results. AWR scores in all EA (1 mA and 3 mA) and Mox (43 degrees C and 46 degrees C) treatment groups after colorectal distention (CRD) stimulation pressure of 20, 40, 60, and 80 mm Hg were significantly lower than those of the model (MC) group (P all < 0.01). The MC counts and degranulation rates in the colon of all EA and Mox treatment groups and the MC group were significantly higher than those of the NC group (P all < 0.01). MC degranulation rates in the colon of all EA and Mox treatment groups were lower than those of the MC group (P all < 0.05). 5-HT expression in colon of all EA and Mox treatment groups was significantly lower than that of the MC group (P all < 0.01), and 5-HT4R expression in colon of both EA groups was significantly higher than that of the MC group (P both < 0.01). Conclusion. EA andMox treatments may both ameliorate visceral hypersensitivity at different degree in rats with C-IBS, and EA treatment was better than Mox.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome
    Cui, Xiu-Fang
    Zhou, Wei-Mei
    Yang, Yan
    Zhou, Jun
    Li, Xue-Liang
    Lin, Lin
    Zhang, Hong-Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (37) : 13521 - 13529
  • [42] The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
    Klooker, Tamira K.
    Braak, Breg
    Koopman, Karin E.
    Welting, Olaf
    Wouters, Mira M.
    van der Heide, Sicco
    Schemann, Michael
    Bischoff, Stephan C.
    van den Wijngaard, Rene M.
    Boeckxstaens, Guy E.
    GUT, 2010, 59 (09) : 1213 - 1221
  • [43] MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats
    Hou, Qiuke
    Huang, Yongquan
    Zhang, Changrong
    Zhu, Shuilian
    Li, Peiwu
    Chen, Xinlin
    Hou, Zhengkun
    Liu, Fengbin
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (04) : 656 - 668
  • [44] Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome?: A randomized controlled trial
    Foxx-Orenstein, A. E.
    Camilleri, M.
    Szarka, L. A.
    Mckinzie, S.
    Burton, D.
    Thomforde, G.
    Baxter, K.
    Zinsmeister, A. R.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (10) : 821 - 830
  • [45] PDIA3 gene induces visceral hypersensitivity in rats with irritable bowel syndrome through the dendritic cell-mediated activation of T cells
    Zhuang, Zhaomeng
    Zhang, Lu
    Wang, Xiaoteng
    Tao, Liyuan
    Lv, Bin
    PEERJ, 2016, 4
  • [46] Bifidobacterium longumalleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
    Zhou, Chunhua
    Fang, Xue
    Xu, Jiajia
    Gao, Jun
    Zhang, Ling
    Zhao, Jiulong
    Meng, Yuting
    Zhou, Wei
    Han, Xu
    Bai, Yu
    Li, Zhaoshen
    Zou, Duowu
    GUT MICROBES, 2020, 12 (01) : 1 - 17
  • [47] Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrheapredominant irritable bowel syndrome
    Yu Zhang
    Geng Qin
    De-Rong Liu
    Yan Wang
    Shu-Kun Yao
    World Journal of Gastroenterology, 2019, (02) : 269 - 281
  • [48] Protective effect of Pediococcus pentosaceus Li05 on diarrhea-predominant irritable bowel syndrome in rats
    Wu, Youhe
    Li, Shengjie
    Lv, Longxian
    Jiang, Shiman
    Xu, Lvwan
    Chen, Hui
    Li, Lanjuan
    FOOD & FUNCTION, 2024, 15 (07) : 3692 - 3708
  • [49] Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome
    Lv, Yuanxia
    Wen, Jing
    Fang, Yingying
    Zhang, Haoyuan
    Zhang, Jianwu
    PEPTIDES, 2022, 147
  • [50] 5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome
    Chang, Wen-Ying
    Yang, Yi-Ting
    She, Meng-Ping
    Tu, Chia-Hung
    Lee, Tsung-Chun
    Wu, Ming-Shiang
    Sun, Chin-Hung
    Hsin, Ling-Wei
    Yu, Linda Chia-Hui
    LABORATORY INVESTIGATION, 2022, 102 (09) : 1023 - 1037